Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

SQuIRE reveals locus-specific regulation of interspersed repeat expression.

Yang WR, Ardeljan D, Pacyna CN, Payer LM, Burns KH.

Nucleic Acids Res. 2019 Mar 18;47(5):e27. doi: 10.1093/nar/gky1301.

2.

Alu insertion variants alter mRNA splicing.

Payer LM, Steranka JP, Ardeljan D, Walker J, Fitzgerald KC, Calabresi PA, Cooper TA, Burns KH.

Nucleic Acids Res. 2019 Jan 10;47(1):421-431. doi: 10.1093/nar/gky1086.

3.

Structural variants caused by Alu insertions are associated with risks for many human diseases.

Payer LM, Steranka JP, Yang WR, Kryatova M, Medabalimi S, Ardeljan D, Liu C, Boeke JD, Avramopoulos D, Burns KH.

Proc Natl Acad Sci U S A. 2017 May 16;114(20):E3984-E3992. doi: 10.1073/pnas.1704117114. Epub 2017 May 2.

4.

The Human Long Interspersed Element-1 Retrotransposon: An Emerging Biomarker of Neoplasia.

Ardeljan D, Taylor MS, Ting DT, Burns KH.

Clin Chem. 2017 Apr;63(4):816-822. doi: 10.1373/clinchem.2016.257444. Epub 2017 Feb 10. Review.

5.

Meeting Report: The Role of the Mobilome in Cancer.

Ardeljan D, Taylor MS, Burns KH, Boeke JD, Espey MG, Woodhouse EC, Howcroft TK.

Cancer Res. 2016 Aug 1;76(15):4316-9. doi: 10.1158/0008-5472.CAN-15-3421. Epub 2016 Jul 18.

6.

Inflammation and Cell Death in Age-Related Macular Degeneration: An Immunopathological and Ultrastructural Model.

Ardeljan CP, Ardeljan D, Abu-Asab M, Chan CC.

J Clin Med. 2014;3(4):1542-60. doi: 10.3390/jcm3041542.

7.

Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration.

Ardeljan D, Wang Y, Park S, Shen D, Chu XK, Yu CR, Abu-Asab M, Tuo J, Eberhart CG, Olsen TW, Mullins RF, White G, Wadsworth S, Scaria A, Chan CC.

PLoS One. 2014 Apr 29;9(4):e95900. doi: 10.1371/journal.pone.0095900. eCollection 2014.

8.

Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration.

Chan CC, Ardeljan D.

Adv Exp Med Biol. 2014;801:193-8. doi: 10.1007/978-1-4614-3209-8_25. Review.

9.

Aging is not a disease: distinguishing age-related macular degeneration from aging.

Ardeljan D, Chan CC.

Prog Retin Eye Res. 2013 Nov;37:68-89. doi: 10.1016/j.preteyeres.2013.07.003. Epub 2013 Aug 9. Review.

10.

Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.

Ardeljan D, Meyerle CB, Agron E, Wang JJ, Mitchell P, Chew EY, Zhao J, Maminishkis A, Chan CC, Tuo J.

Eur J Hum Genet. 2013 Oct;21(10):1152-7. doi: 10.1038/ejhg.2013.14. Epub 2013 Feb 20.

11.

Ten Chairpersons of the Ophthalmology Department at Peking Union Medical College.

Chan CC, Ardeljan D.

Asia Pac J Ophthalmol (Phila). 2013 Jan-Feb;2(1):3-8. doi: 10.1097/APO.0b013e318274c44a.

PMID:
26107860
12.

Controversial view of a genetically altered mouse model of focal retinal degeneration.

Chu XK, Wang Y, Ardeljan D, Tuo J, Chan CC.

Bioengineered. 2013 May-Jun;4(3):130-5. doi: 10.4161/bioe.22949. Epub 2012 Nov 29.

13.

Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.

Wang VM, Rosen RB, Meyerle CB, Kurup SK, Ardeljan D, Agron E, Tai K, Pomykala M, Chew EY, Chan CC, Tuo J.

Mol Vis. 2012;18:2578-85. Epub 2012 Oct 20.

14.

Carboxyethylpyrrole plasma biomarkers in age-related macular degeneration.

Ardeljan D, Tuo J, Chan CC.

Drugs Future. 2011 Sep 1;36(9):712-718.

Supplemental Content

Loading ...
Support Center